Literature DB >> 11804980

Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure.

Jens Fielitz1, Andreas Dendorfer, Reinhard Pregla, Elisabeth Ehler, Heinz R Zurbrügg, Jozef Bartunek, Roland Hetzer, Vera Regitz-Zagrosek.   

Abstract

BACKGROUND: The regulation of the cardiac neutral endopeptidase (EC 24.10, NEP) that degrades bradykinin and natriuretic peptides has been investigated in human cardiac hypertrophy and heart failure. Methods and Results- NEP mRNA was quantitated by real-time polymerase chain reaction (PCR) in left ventricular biopsies from patients with aortic valve stenosis (AS, n=19) and heart failure due to dilated cardiomyopathy (DCM, n=14), and control subjects with normal systolic function (CON, n=14). Left ventricular NEP mRNA content was increased 3-fold in AS (P<0.005) and 4.1-fold in DCM (P<0.002). The increase in NEP mRNA was related to the increase in end diastolic pressure in AS and DCM. In a second series, myocardial NEP enzymatic activity was determined. It increased 3.6-fold in AS (P<0.02) and 4-fold in DCM (P<0.002). NEP was localized in the myocardium by immunofluorescence microscopy and in situ PCR to myocytes and nonmyocyte areas and cells.
CONCLUSIONS: Elevated cardiac NEP activity in pressure loaded and failing human hearts may increase the local degradation of bradykinin and natriuretic peptides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804980     DOI: 10.1161/hc0302.103593

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

2.  Beneficial effects of sacubitril/valsartan in heart failure with reduced ejection fraction: pas à cause du BNP?

Authors:  Naveen L Pereira; Viral K Desai; Allan S Jaffe
Journal:  Eur J Heart Fail       Date:  2019-03-04       Impact factor: 15.534

3.  Exercise reverses preamyloid oligomer and prolongs survival in alphaB-crystallin-based desmin-related cardiomyopathy.

Authors:  Alina Maloyan; James Gulick; Charles G Glabe; Rakez Kayed; Jeffrey Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

4.  Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.

Authors:  Aaron J Trask; Leanne Groban; Brian M Westwood; Jasmina Varagic; Detlev Ganten; Patricia E Gallagher; Mark C Chappell; Carlos M Ferrario
Journal:  Am J Hypertens       Date:  2010-03-18       Impact factor: 2.689

5.  Natriuretic peptide pharmacogenetics: membrane metallo-endopeptidase (MME): common gene sequence variation, functional characterization and degradation.

Authors:  Naveen L Pereira; Pinar Aksoy; Irene Moon; Yi Peng; Margaret M Redfield; John C Burnett; Eric D Wieben; Vivien C Yee; Richard M Weinshilboum
Journal:  J Mol Cell Cardiol       Date:  2010-08-06       Impact factor: 5.000

6.  Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure.

Authors:  Toshiyuki Maki; Yoshihisa Nasa; Kouichi Tanonaka; Masaya Takahashi; Satoshi Takeo
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

Review 7.  The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases.

Authors:  Angelino Calderone
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

8.  Angiotensin-(1-7)-mediated signaling in cardiomyocytes.

Authors:  Enéas R M Gomes; Robson A S Santos; Silvia Guatimosim
Journal:  Int J Hypertens       Date:  2012-03-04       Impact factor: 2.420

Review 9.  cGMP Signaling and Modulation in Heart Failure.

Authors:  Robert M Blanton
Journal:  J Cardiovasc Pharmacol       Date:  2020-05       Impact factor: 3.271

Review 10.  The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.

Authors:  Massimo Volpe; Marino Carnovali; Vittoria Mastromarino
Journal:  Clin Sci (Lond)       Date:  2016-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.